Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 25

1.

Lung alveolar epithelium and interstitial lung disease.

Corvol H, Flamein F, Epaud R, Clement A, Guillot L.

Int J Biochem Cell Biol. 2009 Aug-Sep;41(8-9):1643-51. doi: 10.1016/j.biocel.2009.02.009. Epub 2009 Feb 23. Review.

PMID:
19433305
2.

Gene expression profiles of acute exacerbations of idiopathic pulmonary fibrosis.

Konishi K, Gibson KF, Lindell KO, Richards TJ, Zhang Y, Dhir R, Bisceglia M, Gilbert S, Yousem SA, Song JW, Kim DS, Kaminski N.

Am J Respir Crit Care Med. 2009 Jul 15;180(2):167-75. doi: 10.1164/rccm.200810-1596OC. Epub 2009 Apr 10. Erratum in: Am J Respir Crit Care Med. 2009 Aug 15;180(4):380.

3.

Loss of RAGE in pulmonary fibrosis: molecular relations to functional changes in pulmonary cell types.

Queisser MA, Kouri FM, Königshoff M, Wygrecka M, Schubert U, Eickelberg O, Preissner KT.

Am J Respir Cell Mol Biol. 2008 Sep;39(3):337-45. doi: 10.1165/rcmb.2007-0244OC. Epub 2008 Apr 17.

PMID:
18421017
4.

A role for the receptor for advanced glycation end products in idiopathic pulmonary fibrosis.

Englert JM, Hanford LE, Kaminski N, Tobolewski JM, Tan RJ, Fattman CL, Ramsgaard L, Richards TJ, Loutaev I, Nawroth PP, Kasper M, Bierhaus A, Oury TD.

Am J Pathol. 2008 Mar;172(3):583-91. doi: 10.2353/ajpath.2008.070569. Epub 2008 Feb 2.

5.

Trauma-associated lung injury differs clinically and biologically from acute lung injury due to other clinical disorders.

Calfee CS, Eisner MD, Ware LB, Thompson BT, Parsons PE, Wheeler AP, Korpak A, Matthay MA; Acute Respiratory Distress Syndrome Network, National Heart, Lung, and Blood Institute..

Crit Care Med. 2007 Oct;35(10):2243-50.

6.

Pathogenetic and prognostic significance of altered coagulation and fibrinolysis in acute lung injury/acute respiratory distress syndrome.

Ware LB, Matthay MA, Parsons PE, Thompson BT, Januzzi JL, Eisner MD; National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome Clinical Trials Network..

Crit Care Med. 2007 Aug;35(8):1821-8.

7.

[Outcome of patients with acute exacerbation of idiopathic interstitial fibrosis (IPF) treated with sivelestat and the prognostic value of serum KL-6 and surfactant protein D].

Nakamura M, Ogura T, Miyazawa N, Tagawa A, Kozawa S, Watanuki Y, Takahashi H.

Nihon Kokyuki Gakkai Zasshi. 2007 Jun;45(6):455-9. Japanese.

PMID:
17644940
8.

Acute exacerbations of idiopathic pulmonary fibrosis.

Collard HR, Moore BB, Flaherty KR, Brown KK, Kaner RJ, King TE Jr, Lasky JA, Loyd JE, Noth I, Olman MA, Raghu G, Roman J, Ryu JH, Zisman DA, Hunninghake GW, Colby TV, Egan JJ, Hansell DM, Johkoh T, Kaminski N, Kim DS, Kondoh Y, Lynch DA, Müller-Quernheim J, Myers JL, Nicholson AG, Selman M, Toews GB, Wells AU, Martinez FJ; Idiopathic Pulmonary Fibrosis Clinical Research Network Investigators..

Am J Respir Crit Care Med. 2007 Oct 1;176(7):636-43. Epub 2007 Jun 21. Review.

9.

Acute exacerbation (acute lung injury of unknown cause) in UIP and other forms of fibrotic interstitial pneumonias.

Churg A, Müller NL, Silva CI, Wright JL.

Am J Surg Pathol. 2007 Feb;31(2):277-84.

PMID:
17255773
10.

Role of epithelial cells in idiopathic pulmonary fibrosis: from innocent targets to serial killers.

Selman M, Pardo A.

Proc Am Thorac Soc. 2006 Jun;3(4):364-72. Review.

PMID:
16738202
11.

Classification and natural history of the idiopathic interstitial pneumonias.

Kim DS, Collard HR, King TE Jr.

Proc Am Thorac Soc. 2006 Jun;3(4):285-92. Review.

12.

Receptor for advanced glycation end-products is a marker of type I cell injury in acute lung injury.

Uchida T, Shirasawa M, Ware LB, Kojima K, Hata Y, Makita K, Mednick G, Matthay ZA, Matthay MA.

Am J Respir Crit Care Med. 2006 May 1;173(9):1008-15. Epub 2006 Feb 2.

13.

Acute exacerbation of idiopathic pulmonary fibrosis: frequency and clinical features.

Kim DS, Park JH, Park BK, Lee JS, Nicholson AG, Colby T.

Eur Respir J. 2006 Jan;27(1):143-50.

14.

Anticoagulant therapy for idiopathic pulmonary fibrosis.

Kubo H, Nakayama K, Yanai M, Suzuki T, Yamaya M, Watanabe M, Sasaki H.

Chest. 2005 Sep;128(3):1475-82.

PMID:
16162746
15.

Lower tidal volume ventilation and plasma cytokine markers of inflammation in patients with acute lung injury.

Parsons PE, Eisner MD, Thompson BT, Matthay MA, Ancukiewicz M, Bernard GR, Wheeler AP; NHLBI Acute Respiratory Distress Syndrome Clinical Trials Network..

Crit Care Med. 2005 Jan;33(1):1-6; discussion 230-2.

PMID:
15644641
16.

Elevated plasma levels of soluble TNF receptors are associated with morbidity and mortality in patients with acute lung injury.

Parsons PE, Matthay MA, Ware LB, Eisner MD; National Heart, Lung, Blood Institute Acute Respiratory Distress Syndrome Clinical Trials Network..

Am J Physiol Lung Cell Mol Physiol. 2005 Mar;288(3):L426-31. Epub 2004 Oct 29.

17.

Significance of von Willebrand factor in septic and nonseptic patients with acute lung injury.

Ware LB, Eisner MD, Thompson BT, Parsons PE, Matthay MA.

Am J Respir Crit Care Med. 2004 Oct 1;170(7):766-72. Epub 2004 Jun 16.

PMID:
15201135
18.

Plasma surfactant protein levels and clinical outcomes in patients with acute lung injury.

Eisner MD, Parsons P, Matthay MA, Ware L, Greene K; Acute Respiratory Distress Syndrome Network..

Thorax. 2003 Nov;58(11):983-8.

19.

Elevation of KL-6, a lung epithelial cell marker, in plasma and epithelial lining fluid in acute respiratory distress syndrome.

Ishizaka A, Matsuda T, Albertine KH, Koh H, Tasaka S, Hasegawa N, Kohno N, Kotani T, Morisaki H, Takeda J, Nakamura M, Fang X, Martin TR, Matthay MA, Hashimoto S.

Am J Physiol Lung Cell Mol Physiol. 2004 Jun;286(6):L1088-94. Epub 2003 Sep 5.

20.

The acute respiratory distress syndrome.

Ware LB, Matthay MA.

N Engl J Med. 2000 May 4;342(18):1334-49. Review. No abstract available.

PMID:
10793167

Supplemental Content

Support Center